These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8548329)
1. Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles. Park IW; Sodroski J J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):506-10. PubMed ID: 8548329 [TBL] [Abstract][Full Text] [Related]
2. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins. Wu X; Liu H; Xiao H; Kappes JC Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547 [TBL] [Abstract][Full Text] [Related]
3. Targeting a foreign protein into virion particles by fusion with the Vpx protein of simian immunodeficiency virus. Park IW; Sodroski J J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):341-50. PubMed ID: 8601220 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Zhang C; Rasmussen C; Chang LJ Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266 [TBL] [Abstract][Full Text] [Related]
5. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx. Philippon V; Matsuda Z; Essex M J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368 [TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the vpx, vpr, and nef genes of simian immunodeficiency virus. Park IW; Sodroski J J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):335-44. PubMed ID: 7882097 [TBL] [Abstract][Full Text] [Related]
7. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Kappes JC; Parkin JS; Conway JA; Kim J; Brouillette CG; Shaw GM; Hahn BH Virology; 1993 Mar; 193(1):222-33. PubMed ID: 8438567 [TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. Mahalingam S; Van Tine B; Santiago ML; Gao F; Shaw GM; Hahn BH J Virol; 2001 Jan; 75(1):362-74. PubMed ID: 11119605 [TBL] [Abstract][Full Text] [Related]
9. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest. Wei W; Guo H; Han X; Liu X; Zhou X; Zhang W; Yu XF Cell Microbiol; 2012 Nov; 14(11):1745-56. PubMed ID: 22776683 [TBL] [Abstract][Full Text] [Related]
10. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques. Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822 [TBL] [Abstract][Full Text] [Related]
11. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection. Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664 [TBL] [Abstract][Full Text] [Related]
12. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685 [TBL] [Abstract][Full Text] [Related]
13. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect. Kewalramani VN; Park CS; Gallombardo PA; Emerman M Virology; 1996 Apr; 218(2):326-34. PubMed ID: 8610459 [TBL] [Abstract][Full Text] [Related]
14. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions. Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823 [TBL] [Abstract][Full Text] [Related]
15. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364 [TBL] [Abstract][Full Text] [Related]
16. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm). Accola MA; Bukovsky AA; Jones MS; Göttlinger HG J Virol; 1999 Dec; 73(12):9992-9. PubMed ID: 10559313 [TBL] [Abstract][Full Text] [Related]
17. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. Matsuda Z; Yu X; Yu QC; Lee TH; Essex M Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710 [TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. Mahalingam S; Patel M; Collman RG; Srinivasan A Virology; 1995 Dec; 214(2):647-52. PubMed ID: 8553570 [TBL] [Abstract][Full Text] [Related]
19. Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. Mahnke LA; Belshan M; Ratner L Virology; 2006 Apr; 348(1):165-74. PubMed ID: 16457868 [TBL] [Abstract][Full Text] [Related]
20. Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: amount of Vpr in relation to Gag in HIV-1. Singh SP; Lai D; Cartas M; Serio D; Murali R; Kalyanaraman VS; Srinivasan A Virology; 2000 Mar; 268(2):364-71. PubMed ID: 10704344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]